Circulating microRNA-375 as biomarker of pancreatic beta cell death and protection of beta cell mass by cytoprotective compounds

PLoS ONE

Volumn 12, Issue 10, 2017, Pages

  Song, Imane ^a   Roels, Sarah ^b   Martens, Geert A ^b   Bouwens, Luc ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b DIABETES RESEARCH CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOPROTECTIVE AGENT; EXENDIN 4; GLUCOSE; MICRORNA; MICRORNA 375; PHENYLPROPENOIC ACID GLUCOSIDE; STREPTOZOCIN; UNCLASSIFIED DRUG; 2-(GLUCOPYRANOSYLOXY)-3-PHENYLPROPENOIC ACID; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLUCOSIDE; MIRN375 MICRORNA, MOUSE; PEPTIDE; PHENYLPROPIONIC ACID DERIVATIVE; PROTECTIVE AGENT; VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY WEIGHT; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CELL VOLUME; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; MALE; MIN6 CELL LINE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TISSUE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL LINE; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GENETICS; METABOLISM; PANCREAS; PATHOLOGY;

ANIMALS; APOPTOSIS; BIOMARKERS; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSIDES; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; PANCREAS; PEPTIDES; PHENYLPROPIONATES; PROTECTIVE AGENTS; STREPTOZOCIN; VENOMS;

EID: 85031822102     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0186480     Document Type: Article

References (26)

1. Cnop M, Welsh N, Jonas JC, Jo A, Lenzen S. Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes. Diabetes. 2005; 54: S97–107. https://doi.org/10.2337/diabetes.54.suppl_2.S97PMID: 16306347
2. Matveyenko AV, Butler PC. Relationship between β-cell mass and diabetes onset. Diabetes, Obes Metab. 2008; 10: 23–31. https://doi.org/10.1111/j.1463-1326.2008.00939.x PMID: 18834430
3. Lee MS, Kim KA, Kim HS. Role of Pancreatic β-Cell Death and Cell Death-Associated Inflammation in Diabetes. Curr Mol Med. 2012; 12: 1297–1310. https://doi.org/10.2174/156652412803833553 PMID: 22834831
4. Weir GC, Bonner-Weir S. Islet β cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci. 2013; 1281: 92–105. https://doi.org/10.1111/nyas.12031 PMID: 23363033
5. Meier JJ. Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia. 2008; 51: 703–713. https://doi.org/10.1007/s00125-008-0936-9 PMID: 18317728
6. Karaca M, Magnan C, Kargar C. Functional pancreatic beta-cell mass: Involvement in type 2 diabetes and therapeutic intervention. Diabetes Metab. 2009; 35: 77–84. https://doi.org/10.1016/j.diabet.2008.09.007 PMID: 19251449
7. Harrison C. Target identification: Stopping β-cell death in diabetes. Nat Rev Drug Discov. 2014; 13: 333. https://doi.org/10.1038/nrd4313 PMID: 24722464
8. Song I, Muller C, Louw J, Bouwens L. Regulating the Beta Cell Mass as a Strategy for Type-2 Diabetes Treatment. Curr Drug Targets. 2015; 16: 516–524. https://doi.org/10.2174/ 1389450116666150204113928 PMID: 25654737
9. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004; 429: 41–46. https://doi.org/10.1038/nature02520 PMID: 15129273
10. Mathijs I, Da Cunha DA, Himpe E, Ladriere L, Chellan N, Roux CR, et al. Phenylpropenoic acid glucoside augments pancreatic beta cell mass in high-fat diet-fed mice and protects beta cells from ER stress-induced apoptosis. Mol Nutr Food Res. 2014; 58: 1980–1990. https://doi.org/10.1002/mnfr. 201400211 PMID: 25044754
11. Muller CJF, Joubert E, Pheiffer C, Ghoor S, Sanderson M, Chellan N, et al. Z-2-(β-D-glucopyranosy-loxy)-3-phenylpropenoic acid, an α-hydroxy acid from rooibos (Aspalathus linearis) with hypoglycemic activity. Mol Nutr Food Res. 2013; 57: 2216–2222. https://doi.org/10.1002/mnfr.201300294 PMID: 23943314
12. Himpe E, Cunha DA, Song I, Bugliani M, Marchetti P, Cnop M, et al. Phenylpropenoic Acid Glucoside from Rooibos Protects Pancreatic Beta Cells against Cell Death Induced by Acute Injury. PLoS One. 2016; 11: e0157604. https://doi.org/10.1371/journal.pone.0157604 PMID: 27299564
13. Gotthardt M, Eizirik DL, Cnop M, Brom M. Beta cell imaging—a key tool in optimized diabetes prevention and treatment. Trends Endocrinol Metab. 2014; 25: 375–377. https://doi.org/10.1016/j.tem.2014.02.002 PMID: 24726483
14. Farr RJ, Joglekar M V, Taylor CJ, Hardikar AA. Circulating non-coding RNAs as biomarkers of beta cell death in diabetes. Pediatr Endocrinol Rev. 2013; 11: 14–20. PMID: 24079075
15. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011; 39: 7223–7233. https://doi.org/10.1093/nar/gkr254 PMID: 21609964
16. Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A. 2009; 106: 5813–5818. https://doi.org/10.1073/pnas.0810550106 PMID: 19289822
17. Erener S, Mojibian M, Fox JK, Denroche HC, Kieffer TJ. Circulating miR-375 as a Biomarker of β-Cell Death and Diabetes in Mice. Endocrinology. 2013; 154: 603–608. https://doi.org/10.1210/en.2012-1744PMID: 23321698
18. Kanak MA, Takita M, Shahbazov R, Lawrence MC, Chung WY, Dennison AR, et al. Evaluation of Micro-rna375 as a Novel Biomarker for Graft Damage in Clinical Islet Transplantation. Transplantation. 2015; 99: 1568–1573. https://doi.org/10.1097/TP.0000000000000625 PMID: 25769078
19. Latreille M, Herrmanns K, Renwick N, Tuschl T, Malecki MT, McCarthy MI, et al. miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development. J Mol Med. 2015; 93: 1159–1169. https://doi.org/10.1007/s00109-015-1296-9 PMID: 26013143
20. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008; 51: 216–226. https://doi.org/10.1007/s00125-007-0886-7 PMID: 18087688
21. Silva MT. Secondary necrosis: The natural outcome of the complete apoptotic program. FEBS Lett. 2010; 584: 4491–4499. https://doi.org/10.1016/j.febslet.2010.10.046 PMID: 20974143
22. Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011; 48: 61–69. https://doi.org/10.1007/s00592-010-0226-0 PMID: 20857148
23. Sun K, Chang X, Yin L, Li J, Zhou T, Zhang C, et al. Expression and DNA methylation status of microRNA-375 in patients with type 2 diabetes mellitus. Mol Med Rep. 2013; 9: 967–972. https://doi.org/10.3892/mmr.2013.1872 PMID: 24366165
24. Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, et al. GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 2006; 4: 391–406. https://doi.org/10.1016/j.cmet.2006.10.001 PMID: 17084712
25. Tortosa F, Dotta F. Incretin hormones and beta-cell mass expansion: what we know and what is missing? Arch Physiol Biochem. 2013; 119: 161–169. https://doi.org/10.3109/13813455.2013.795175PMID: 23697580
26. Tamura K, Minami K, Kudo M, Iemoto K, Takahashi H, Seino S. Liraglutide Improves Pancreatic Beta Cell Mass and Function in Alloxan-Induced Diabetic Mice. PLoS One. 2015; 10: e0126003. https://doi.org/10.1371/journal.pone.0126003 PMID: 25938469